Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
8,311,195
-
Share change
-
-3,446,533
-
Total reported value
-
$23,687,285
-
Price per share
-
$2.85
-
Number of holders
-
28
-
Value change
-
-$5,592,819
-
Number of buys
-
13
-
Number of sells
-
9
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q3 2025
As of 30 Sep 2025,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,311,195 shares.
The largest 10 holders included
Long Focus Capital Management, LLC, B Group, Inc., MACQUARIE GROUP LTD, CITADEL ADVISORS LLC, MORGAN STANLEY, LPL Financial LLC, MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BNP PARIBAS FINANCIAL MARKETS, and UBS Group AG.
This page lists
28
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.